IN8bio, Inc.
NASDAQ:INAB
0.2802 (USD) • At close January 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 21.282 | 18.182 | 37.021 | 17.994 | 0.61 | 4.99 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 21.282 | 18.182 | 37.021 | 17.994 | 0.61 | 4.99 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0.03 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0.015 |
| Other Current Assets
| 3.343 | 7.872 | 3.866 | 0.15 | 0.153 | 0.052 |
| Total Current Assets
| 24.625 | 22.234 | 38.98 | 18.144 | 0.763 | 5.072 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 8.573 | 10.298 | 2.834 | 0.186 | 0.274 | 0.795 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0.126 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0.126 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.252 | 0.251 | 0 | 0 | 0 |
| Tax Assets
| 0 | -0.252 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.511 | 0.381 | 0.158 | 2.58 | 0.093 | 0.028 |
| Total Non-Current Assets
| 9.084 | 10.805 | 3.243 | 2.766 | 0.367 | 0.823 |
| Total Assets
| 33.709 | 33.039 | 42.223 | 20.91 | 1.13 | 5.895 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.924 | 2.091 | 0.395 | 0.62 | 0.56 | 0.419 |
| Short Term Debt
| 1.514 | 2.778 | 1.252 | 0.174 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.955 | 0.953 | 0.609 | 1.778 | 0.087 | 0 |
| Total Current Liabilities
| 5.393 | 5.822 | 2.256 | 2.572 | 0.647 | 0.419 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 3.379 | 4.485 | 1.784 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.017 | 0.829 | 0.829 |
| Total Non-Current Liabilities
| 3.379 | 4.485 | 1.784 | 0.017 | 0.829 | 0.829 |
| Total Liabilities
| 8.772 | 10.307 | 4.04 | 2.589 | 1.476 | 1.248 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 42.223 | 34.9 | 8.896 | 8.896 |
| Common Stock
| 0.004 | 0.003 | 0.002 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -91.219 | -61.212 | -32.691 | -18.038 | -9.481 | -4.347 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -42.223 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 116.152 | 83.941 | 70.872 | 1.458 | 0.238 | 0.097 |
| Total Shareholders Equity
| 24.937 | 22.732 | 38.183 | 18.321 | -0.346 | 4.647 |
| Total Equity
| 24.937 | 22.732 | 38.183 | 18.321 | -0.346 | 4.647 |
| Total Liabilities & Shareholders Equity
| 33.709 | 33.039 | 42.223 | 20.91 | 1.13 | 5.895 |